Literature DB >> 12748492

The impact of urodynamic stress incontinence and detrusor overactivity on marital relationship and sexual function.

Shing-Kai Yip1, Alice Chan, Selina Pang, Peter Leung, Catherine Tang, Daniel Shek, Tony Chung.   

Abstract

OBJECTIVE: We assessed and compared the quality of life, marital relationship, and sexual function of women who had urodynamic stress incontinence (USI) or detrusor overactivity (DO) diagnosed. STUDY
DESIGN: Women with the following urodynamic diagnoses, normal, USI, or DO, were compared by using the psychometric questionnaires: King's Health Questionnaire (KHQ, for quality of life), Dyadic Adjustment Scale (DAS, for marital relationship), and Derogatis Sexual Functioning Inventory (DSFI, for sexual function).
RESULTS: Women with DO (n = 29) were younger than healthy women (n = 28) and women with USI (n = 36) (P <.05). Women with USI or DO had a poorer quality of life (P <.05), poorer marital relationship (P <.05), and less sexual satisfaction (P <.05), despite having no change in sexual drive (P >.05). Regression analyses showed that only sexual satisfaction and incontinence-related emotions were associated with marital relationship (P <.05).
CONCLUSION: Marital relationship and sexual function were negatively affected in women who had USI or DO.

Entities:  

Mesh:

Year:  2003        PMID: 12748492     DOI: 10.1067/mob.2003.273

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  29 in total

Review 1.  Pharmacological management of women with mixed urinary incontinence.

Authors:  Hashim Hashim; Paul Abrams
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Biofeedback versus electrical stimulation for sexual dysfunction: a randomized clinical trial.

Authors:  Behnaz Aalaie; Behroz Tavana; Zahra Rezasoltani; Solmaz Aalaei; Jamshid Ghaderi; Afsaneh Dadarkhah
Journal:  Int Urogynecol J       Date:  2020-06-11       Impact factor: 2.894

3.  Female sexual function following surgery for stress urinary incontinence: tension-free vaginal versus transobturator tape procedure.

Authors:  Loïc Sentilhes; Aurélien Berthier; Cécile Loisel; Philippe Descamps; Loïc Marpeau; Philippe Grise
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-12-17

4.  Surgical treatment for female stress urinary incontinence: what is the gold-standard procedure?

Authors:  Maurizio Serati; Stefano Salvatore; Stefano Uccella; Walter Artibani; Giacomo Novara; Linda Cardozo; PierFrancesco Bolis
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-06

5.  A 12-month feasibility study to investigate the effectiveness of cryogen-cooled monopolar radiofrequency treatment for female stress urinary incontinence.

Authors:  Bruce B Allan; Stacie Bell; Kathryn Husarek
Journal:  Can Urol Assoc J       Date:  2020-07       Impact factor: 1.862

6.  Symptoms, quality of life, and factors affecting women's treatment decisions regarding pelvic organ prolapse.

Authors:  Symphorosa Shing Chee Chan; Rachel Yau Kar Cheung; Ka Wah Yiu; Lai Loi Lee; Albe Wai Lam Pang; Tony Kwok Hung Chung
Journal:  Int Urogynecol J       Date:  2012-03-08       Impact factor: 2.894

7.  The effect of overactive bladder treatment with anticholinergics on female sexual function in women: a prospective observational study.

Authors:  Suleyman Sami Cakir; Recep Burak Degirmentepe; Hasan Anil Atalay; Halil Lutfi Canat; Sait Ozbir; Mehmet Gokhan Culha; Emre Can Polat; Alper Otunctemur
Journal:  Int Urol Nephrol       Date:  2018-11-17       Impact factor: 2.370

8.  Urinary Incontinence and Psychosocial Factors Associated With Intimate Relationship Satisfaction Among Midlife Women.

Authors:  Lori Saiki; Robin Meize-Grochowski
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2017-05-04

Review 9.  Urinary disorders and female sexual function.

Authors:  Jaclyn Chen; Genevieve Sweet; Alan Shindel
Journal:  Curr Urol Rep       Date:  2013-08       Impact factor: 3.092

10.  Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin.

Authors:  Tondalaya Gamble; Peter Sand
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.